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Introduction
Since its discovery a decade ago (Deak et al., 1997), matrilin 2 has
attracted the attention of researchers because of its wide distribution
in the extracellular matrix (ECM) of different tissues and interesting
molecular structure predicting functionally important molecular
interactions. Matrilin 2 shares a similar modular structure with the
other matrilin family members, matrilin 1 and matrilin 3 primarily
expressed in cartilage and the ubiquitously expressed matrilin 4
(Wagener et al., 2005). Analysis of mouse and human matrilin-2
cDNA sequences has revealed that the precursor protein contains a
putative signal peptide, two von Willebrand factor A (VWA)-like
modules separated by ten epidermal growth factor (EGF)-like motifs,
a unique segment not identified in other proteins and a coiled-coil
(CC) oligomerization domain (Deak et al., 1997). This structure, in
particular the vWFA modules, have predicted possibilities for versatile
protein-protein interactions. And indeed, in tissue extracts and cell
culture medium, matrilin 2 exists as mono-, di-, tri- and tetramers
(Piecha et al., 1999). In addition, biochemical and biophysical
characterization of matrilin CC domains have revealed the potential
for heterotrimeric interactions between matrilin 2 and matrilin 1 or
matrilin 4 (Frank et al., 2002). In addition, several other ECM ligands
for matrilin 2, such as different types of collagen, fibrillin 1, fibrillin
2, laminin and fibronectin, have been identified using surface plasmon
resonance and electron microscopy (Piecha et al., 2002). Thus,
matrilin 2 is a widespread ECM component that can interact with
itself and with other collagenous and non-collagenous matrix
molecules. This broad interaction repertoire, together with its
oligomeric structure, render matrilin 2 a good candidate as an adapter
or mediator molecule for interactions between other matrix
macromolecules during the assembly of the ECM.
Despite this knowledge, the specific functions of matrilin 2 are
currently unknown because the recently generated matrilin-2-
knockout mouse has not revealed any apparent phenotypes (Mates
et al., 2004). Based on previous data on the expression of matrilin
2 in the perineurium of peripheral nerves, among various other
mouse organs and tissues (Deak et al., 1997; Piecha et al., 1999),
and our own data demonstrating the expression in developing dorsal
root ganglia and in Schwann cells (SCs) after nerve injury, we
hypothesized that matrilin 2 might be important for cellular
interactions and repair processes in the peripheral nervous system.
To test this hypothesis, we devised experiments using a spectrum
of approaches to characterize the influences of matrilin 2, or its
absence, on the behaviour of SCs and peripheral neurons in vitro.
These experiments showed that matrilin 2 profoundly influences
cell migration and axonal outgrowth in vitro. Taking advantage of
a recently developed femoral nerve injury paradigm allowing
Matrilins are adaptor proteins of the extracellular matrix
involved in the formation of both collagen-dependent and
collagen-independent filamentous networks. Although their
molecular structure and binding partners have been
characterized, the functional roles of the four matrilin family
members in vivo are still largely unknown. Here, we show that
matrilin 2, expressed in pre-myelinating Schwann cells during
normal development, profoundly influences the behaviour of
glial cells and neurons in vitro. When offered as a uniform
substrate, matrilin 2 increased neurite outgrowth of dorsal root
ganglia (DRG) neurons and enhanced the migration of both cell
line- and embryonic DRG-derived Schwann cells. Vice versa,
axonal outgrowth and cell migration were decreased in DRG
cultures prepared from matrilin-2-deficient mice compared with
wild-type (wt) cultures. In stripe assays, matrilin 2 alone was
sufficient to guide axonal growth and, interestingly, axons
favoured the combination of matrilin 2 and laminin over
laminin alone. In vivo, matrilin 2 was strongly upregulated in
injured peripheral nerves of adult wild-type mice and failure
of protein upregulation in knockout mice resulted in delayed
regrowth of regenerating axons and delayed time-course of
functional recovery. Strikingly, the functional recovery 2 months
after nerve injury was inferior in matrilin-2-deficient mice
compared with wild-type littermates, although motoneuron
survival, quality of axonal regeneration, estimated by analyses
of axonal diameters and degrees of myelination, and Schwann
cell proliferation were not influenced by the mutation. These
results show that matrilin 2 is a permissive substrate for axonal
growth and cell migration, and that it is required for successful
nerve regeneration.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/7/995/DC1
Key words: Schwann cells, Axonal outgrowth, Extracellular matrix,
Coating substrates, Cell migration, Peripheral nerve regeneration
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precise evaluation of motor recovery and subsequent morphological
evaluation of nerve regeneration in the same animals (Irintchev et
al., 2005; Simova et al., 2006), we compared functional recovery
in adult matrilin-2-deficient mice and wild-type littermates. The
combined results of our analyses provide novel evidence for the
functional importance of matrilin 2 in nerve regeneration.
Results
Matrilin 2 is expressed in Schwann cells
In order to determine the cell types expressing matrilin-2 mRNAs
in the developing PNS we used, in addition to wild-type mice,
ErbB3-deficient embryos. These embryos lack SC precursors along
peripheral nerves (Britsch et al., 1998; Riethmacher et al., 1997),
a feature that aids expression profiling in the PNS. Using in situ
hybridization, we found that matrilin 2 was expressed in DRG and
along peripheral nerves throughout development of wild-type
embryos (Fig. 1C,E,F), whereas in ErbB3-deficient embryos, no
matrilin 2 was detectable in peripheral nerves, and the expression
level was much lower than in wild-type embryos within the DRG
(Fig. 1D). This result was confirmed by semi-quantitative RT-PCR
of cDNA prepared from DRG where the signal was severely reduced
in samples from ErbB3-deficient embryos compared with the wild-
type control (Fig. 1A). By immunohistochemistry matrilin 2 was
found in developing DRG and in the endoneurium of developing
spinal nerves, as well as in the spinal dura mater and the epineurium
(supplementary material Fig. S3). Furthermore, the expression of
matrilin 2 was analyzed in different cell types by semi-quantitative
RT-PCR. Matrilin 2 was found to be expressed by at least two SC
types: S16 cells (an immortalized SC line from rat sciatic nerve)
and primary embryonic SCs (ESCs) (prepared from DRG of mouse
embryos), whereas the precursor of embryonic SCs, neural crest
stem cells, do not express matrilin 2 (Fig. 1B).
Matrilin 2 promotes adhesion and migration of immortalized
S16 Schwann cells in vitro
Next, we sought to identify effects of matrilin 2 on SC behaviour
in vitro. Using a cell adhesion assay, we found that matrilin 2
strongly promotes S16 SC adhesion compared with uncoated
plastic substrate. This effect was, however, less pronounced than
the degree of laminin- or fibronectin-mediated adhesion (Fig. 2A).
We then analyzed the ability of matrilin 2 to promote SC migration,
as opposed to other ECM substrates present in peripheral nerves,
such as laminin or fibronectin, using the Varani migration assay
(Varani et al., 1978). This assay measures the migration of cells
from a high-density population of cells contained in an agarose drop
away from it with time (for details see Materials and Methods).
SCs began to migrate out of the drop within 2 hours of plating and
continued to migrate radially for a number of days, producing a
uniform ‘corona’ of cells around the drop. Migration was quantified
daily by measuring the distance between the leading edge of the
corona and the margin of the agarose drop. The results showed that
matrilin 2 significantly promotes SC migration. Unexpectedly, the
degree of promotion by matrilin 2 even exceeded the effects of
laminin or fibronectin that are known promoters of SC migration
(Milner et al., 1997b) (Fig. 2B,C).
Matrilin 2 promotes migration of ESCs from DRG in vitro
As matrilin 2 is expressed in ESCs, we next investigated the effect
of matrilin 2 on ESC migration. DRG cultures were prepared from
wild-type embryos (E12) and grown on different ECM substrates,
including matrilin 2, PDO (poly-D-ornithine), laminin or the
combination of matrilin 2 and laminin. ESCs were visualized by
fluorescence microscopy after incubation with a Sox10-specific
antibody (Fig. 3A). We found enhanced migration of ESCs, both
in terms of numbers of migrating cells and distances of migration,
in cultures grown on either matrilin 2 or the combination of matrilin
2 and laminin, when compared with other substrates (Fig. 3A-C).
In order to investigate whether ablation of matrilin 2 influences
ESC migration, we isolated DRG from wild-type and matrilin-2-
deficient embryos (E12) and cultured them in dishes coated with PDO,
laminin or matrilin 2 in serum-free medium without neurotrophic
factors for 72 hours. Immunostaining with anti-Sox10 antibodies and
nuclear counterstaining with DAPI revealed a significant decrease
of the number of migrating ESCs in cultures from matrilin-2-
deficient embryos on PDO (data not shown) and laminin (Fig. 3D,E),
which is in good agreement with our previous results. However, when
DRG were grown on matrilin-2-coated surfaces, no significant
Journal of Cell Science 122 (7)
Fig. 1. Different expression pattern of matrilin 2 in wild-type and ErbB3–/–
embryos, and analysis of matrilin-2 expression levels in different cell types.
(A) Semi-quantitative RT-PCR using cDNA prepared from DRG of wild-type
and ErbB3-mutant embryos. GAPDH was used as an internal control. At
comparable GAPDH levels, much higher levels of matrilin-2-specific
amplicons were present in wild type compared with mutant extracts.
(B) Analysis of matrilin-2 expression by semi-quantitative RT-PCR. Matrilin 2
is expressed in the rat SC line (S16) and primary embryonic SCs, whereas
there is no expression of matrilin 2 in neural crest stem cells (Monc)
(precursors of embryonic SCs). (C-F) In situ hybridization with 35S-labelled
matrilin-2-specific riboprobe on transverse cryosections of mouse embryos
(E12-18). Arrowheads indicate the expression of matrilin 2 within DRG of
wild-type embryos, whereas the arrows indicate the expression in SCs aligning
axonal projections. Note the absence of the expression along axonal
projections in the ErbB3 mutant embryo at E12 (arrow in D). As almost all
ErBb3-deficient embryos die at E12.5 and the PNS in surviving mutants is
progressively degenerating, no older stages were analysed. Scale bars: 100 µm
(in C for C,D); 125 µm (E); 175 µm (F).
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difference in the migration behaviour of ESCs could be observed
between cultures from wild-type and matrilin-2-deficient embryos
(Fig. 3D). In addition, if matrilin 2 was added to the medium of
matrilin-2-deficient DRG seeded on laminin-coated surfaces, the
number of migrating ESCs was significantly increased and was similar
to migrating ESCs numbers in wild-type cultures on laminin (Fig.
3D,E). This indicates that adding matrilin 2 to the medium or growing
the DRG on matrilin-2-coated surfaces can rescue the migration defect
of matrilin-2-deficient ESC in our culture assay. Addition of matrilin
2 to the medium of cultures grown on matrilin-2-coated surfaces had
no significant enhancing effect (Fig. 3D). Similar results regarding
SC migration were obtained when cultures were grown in the presence
of neurotrophic factors.
Matrilin 2 promotes axonal outgrowth but not axonal branching
of DRG neurons
To analyze the effects of matrilin 2 on outgrowth and branching of
sensory neuron neurites, we cultured DRG explants or dissociated
DRG neurons on different ECM substrates: matrilin 2, laminin or
the combination of laminin and matrilin 2 in serum-free medium
containing growth factors. As shown in Fig. 4A, we found a
significant increase of axonal length on a matrilin-2-coated surface
compared with PDO-coated surface. Interestingly, matrilin 2 was
almost as potent in promoting neurite outgrowth as laminin, one of
the most potent enhancers of axonal growth.
To determine whether axonal outgrowth is decreased in DRG of
matrilin-2-deficient animals, we prepared DRG cultures from wild-
type and matrilin-2-deficient embryos, and cultured them for 48 hours
on PDO, laminin or matrilin-2-coated surfaces. Indeed, quantitative
analysis revealed that axonal length was significantly decreased in
matrilin-2-deficient cultures in comparison with wild-type on PDO
(data not shown) and laminin (Fig. 4B). However, when DRG were
cultured on matrilin-2-coated surfaces, no significant difference in
Fig. 2. Comparison of migration and adhesion of S16 cells on different
extracellular matrix substrates. (A) Effect of matrilin 2 on SC adhesion. SC
suspensions were incubated for 30 minutes in wells of 24-well tissue culture
dishes coated with different ECM substrates. After washing, the adherent cells
were fixed and counted using phase-contrast microscopy. Results are
expressed as a percentage of the number of cells adhering to laminin, which
was normalized to 100%. Statistical analysis showed a significant increase
(***P<0.001) of the numbers of cells adhering to different substrates versus
non-coated (nc) dishes. Note that also the differences in adhesion between
laminin and fibronectin or matrilin 2 are significant. (B,C) S16 SCs migration
on different coating substrates determined by the agarose drop migration assay.
(B) Mean distances of SCs migration on different ECM substrates, fibronectin,
laminin and matrilin 2. All ECM molecules promoted SCs migration
compared with the uncoated control substrate (***P<0.001). In addition, the
distances of migration on matrilin-2 surfaces were significantly increased
(***P<0.001) in comparison with laminin- or fibronectin-coated surfaces.
**P<0.01. (C) Cell migration was analyzed using phase-contrast microscopy.
Scale bar: 100 µm. 
Fig. 3. Matrilin 2 promotes SC migration from embryonic DRG. (A) Cell
migration from wild-type DRG on different ECM substrates. Cells allowed to
migrate for 24 hours on different substrates were visualized by fluorescence
microscopy after incubation with Sox10-specific antibodies. More cells
migrate out of DRG on matrilin 2 and a mixture of matrilin 2 + laminin
compared with just laminin. Scale bar: 250 µm. (B) Mean distances of SC
migration on different substrates. Migration was quantified by measuring the
distance from the edge of a ganglion to the leading edge of migrating SCs on
photomicrographs. Significant differences are indicated (***P<0.001;
*P<0.05). (C) Mean numbers of migrating cells expressed as fold difference
compared with PDO. Significant differences are indicated. In addition, the
numbers of migrating cells on a mixture of laminin and matrilin 2 are
significantly elevated (***P<0.001) compared with migration on laminin or
matrilin 2 alone. (D) Migration of ESCs from DRG prepared from matrilin-2-
deficient and wild-type embryos. Cells were allowed to migrate on laminin
and matrilin-2-coated surfaces with or without addition of matrilin 2 (2 µg/ml)
to the medium for 72 hours. Mean numbers of migrating cells expressed as
fold difference compared with wild-type on laminin. Significant differences
are indicated (***P<0.001). Addition of matrilin 2 to the culture medium had
no significant effect on wild-type cultures (data not shown). (E) DRG from
wild-type (+/+) and matrilin-2-deficient (–/–) embryos grown on laminin for
72 hours without and with the addition of matrilin 2 to the culture medium
(+mat). Note the increase in migrating SCs (Sox10-positive) in matrilin-2-
deficient cultures on laminin after addition of matrilin 2 (+mat) compared with
the mutant culture without matrilin 2. Scale bar: 250 µm.
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axonal length could be detected by comparing wild-type and
matrilin-2-deficient cultures (Fig. 4B). When matrilin 2 was added
to the medium of matrilin-2-deficient DRG grown on laminin, we
could observe a significant increase in axonal length compared with
matrilin-2-deficient DRG grown without added matrilin 2 (Fig. 4B).
However, there still was a small reduction of axonal length compared
with wild-type cultures, indicating that addition of matrilin 2 cannot
completely rescue this phenotype.
When plated on uniform growth-permissive substrates such as
laminin or matrilin 2, dissociated adult DRG neurons started to
elaborate processes within a few hours in vitro. We compared axonal
branching of DRG neurons from young postnatal wild-type mice (P3)
within 12 hours of plating on the following ECM substrates: matrilin
2, laminin and matrilin 2 + laminin. We selected this time-point for
analysis because the neurite trees were already well developed and
quantitative analysis could still be performed in a straightforward
way (Fig. 4C-F). Previous studies have shown that laminin stimulates
neurite extension rather than neurite branching. In the present study,
we found that the effect of matrilin 2 on branching was similar to
that of laminin. On matrilin-2-coated surfaces, DRG axons were
slightly shorter than on laminin (Fig. 4C,D), but the number of
branching points was comparable with those observed on laminin
(Fig. 4F). However, a mixture of matrilin 2 and laminin seems to
enhance branching slightly compared with laminin alone (Fig. 4F).
Matrilin 2 promotes axonal growth of DRG neurons
We next compared the ability of matrilin 2 and laminin, fibronectin
and poly-l-lysine (PLL), to promote axonal growth in a classical
stripe assay. These experiments were carried out in the presence of
NGF to support neuronal survival and to elicit axonal outgrowth.
As shown previously (Vielmetter et al., 1990), in our experiments
DRG neuron axons grew more successfully on laminin compared
with PLL (Fig. 5A). When DRG axons were exposed to alternating
stripes of matrilin 2 and PLL, they always grew more successfully
on matrilin 2 (Fig. 5B), although this effect was not as strong as the
one observed for laminin. When DRG neuron axons were confronted
with alternating stripes of laminin and matrilin 2, or fibronectin and
matrilin 2, axons grew equally well on all substrates (Fig. 5C and
data not shown). Interestingly, when exposed to alternating stripes
of laminin alone and a mixture of laminin and matrilin 2, growth
promotion of DRG neuron axons was enhanced on the mixture of
laminin and matrilin 2 compared with laminin alone (Fig. 5D).
Injury of peripheral nerves in adult mice causes re-expression
of matrilin 2
When we monitored the expression of matrilin 2 in the developing
PNS, we found that the expression is downregulated postnatally (data
not shown). Immunohistochemical and immunoblotting analyses
revealed that matrilin 2 is still expressed in adult peripheral nerves
but at very low levels (Fig. 6B,D). As matrilin 2 is strongly expressed
in the developing PNS and then downregulated in the adult, we next
investigated whether the expression is upregulated following
peripheral nerve injury. Interestingly, at 3 or 5 days after transection
of the femoral or sciatic nerve respectively, we observed a strong
upregulation of matrilin 2 analysed by RT-PCR (data not shown),
immunohistochemistry (Fig. 6A,C) and by western blot analysis (Fig.
6G). The upregulation of matrilin 2 in the distal stump of the injured
nerves appeared slightly stronger than in the proximal part.
Expression of matrilin 2 was observed in the perineurium of lesioned
and intact sciatic nerve, as well as in endoneurium of damaged sciatic
nerves (Fig. 6C,D). Interestingly, the perineurium of the femoral
nerve was either not or only very weakly immunoreactive for matrilin
2 and exhibited no upregulation even after lesion (Fig. 6A,B). As
other members of a family can often compensate if expression of
one member of the family is lost, we looked at the expression of
matrilin 1, matrilin 3 and matrilin 4 in nerves from wild-type and
matrilin-2-deficient animals after lesion. We found no expression of
matrilin 1 and matrilin 3 in wild-type or matrilin-2-deficient nerves
before or after lesion by RT-PCR analysis (data not shown),
indicating that neither matrilin-1 nor matrilin-3 expression show a
compensatory upregulation when matrilin-2 expression is lost.
When we looked at matrilin 4 immunohistochemically, we found
that it was strongly upregulated in nerves of wild-type animals after
lesion, similar to matrilin 2 (Fig. 6E,F). Additionally, the upregulation
of matrilin 4 demonstrated by RT-PCR analysis is significantly
stronger in lesioned nerves from matrilin-2-deficient animals
Journal of Cell Science 122 (7)
Fig. 4. Matrilin 2 promotes axonal outgrowth of DRG neurons but does not
affect branching. (A) Axonal outgrowth from wild-type DRG cultures on
different ECM substrates. Axons were allowed to grow for 24 hours on
different substrates and were then visualized with NF160-specific antibodies.
Significant differences are indicated (***P<0.001; *P<0.05). (B) Axon
outgrowth from DRG neurons prepared from wt (+/+) and matrilin-2-deficient
(–/–) embryos. Axons were grown for 48 hours on laminin (lam.) or matrilin-
2-coated surfaces (mat.) with (+matrilin 2) or without the addition of matrilin 2
to the culture medium. After visualization using NF200-specific antibodies,
the lengths of axons were measured. Significant differences are indicated
(***P<0.001; *P<0.05). Note that axonal outgrowth on matrilin-2-coated
surfaces showed no statistical differences and that addition of matrilin 2 to the
medium on laminin could not fully rescue the mutants. (C-E) Axonal
branching of wild-type DRG neurons on different ECM substrates. Dissociated
DRG neurons were prepared from wild-type pups (P0-P3). Morphology of
neurites of dissociated sensory neurons grown for 12 hours on laminin (C),
matrilin 2 (D) and mixture of laminin and matrilin 2 (E) visualized by β-
tubulin (Tuj1) immunostaining. Scale bar: 25 µm. (F) Quantitative analysis of
the mean number of branching points per main neurites demonstrated similar
ratios of branching points. Note, however, that there is a slight difference in
branching points between laminin and a mixture of laminin and matrilin 2
(*P<0.05).
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compared with wild-type animals (Fig. 6H) 5 days after lesion. A
difference in matrilin-4 expression is also detectable 7 days after
lesion (data not shown).
To further elucidate the tissue distribution of matrilin 2 in the
injured nerve, we performed colocalization analyses using cell type-
and tissue-specific markers (Fig. 7A-H). These studies revealed that
matrilin 2 is not present in axons (Fig. 7A,B), as was expected from
our previous experiments demonstrating that matrilin 2 is expressed
in SCs. Colocalization using antibodies against myelin basic protein
and matrilin 2 clearly showed that matrilin 2 is not incorporated
into the myelin sheaths (Fig. 7C,D). By contrast, a high degree of
colocalization was found between matrilin 2 and p75, the low-
affinity NGF receptor expressed by SCs, (Taniuchi et al., 1986),
(Fig. 7E,F) and nidogen 1, a basal lamina marker (Paulsson et al.,
1987) (Fig. 7G,H). These results indicate that matrilin-2 expression
is upregulated in SCs close to the injury site, both in the proximal
and distal nerve stumps. Furthermore, the secreted protein is
deposited in the endoneural tubes consisting of basal lamina and is
associated with ECM components that guide regenerating axons
after peripheral nerve injury. Similar results were obtained for
matrilin 4 (supplementary material Fig. S2).
Impaired functional recovery of adult matrilin-2-deficient mice
after femoral nerve repair
The finding of a strong upregulation of matrilin 2 in the injured
peripheral nerve, its localization in endoneural tubes known to
support axonal regeneration and its permissive properties for axonal
regrowth in vitro, indicated that matrilin 2 might be functionally
important during nerve regeneration. To address this issue, we used
the femoral nerve injury paradigm and single-frame motion analysis
for numerical evaluation of muscle function (Irintchev et al., 2005).
Two parameters were used for evaluation, the heels-tail angle (HTA)
and foot-base angle (FBA). These two parameters, evaluated from
video recording of beam walking trials, reflect the ability of the
quadriceps muscle to keep the knee extended during single support
phases of the gate cycle and, for the FBA, to counteract in addition
the rotational moments in the hip caused by the swing of the
contralateral extremity. These abilities were severely compromised
after femoral nerve transection and repair in both matrilin-2-deficient
and wild-type mice, as seen from changes of the values of HTA and
FBA between 0 days (prior to operation) and 1 week after operation
(Fig. 8A,B). In the subsequent recovery period, however, restoration
of function, as evaluated by the HTA, a parameter most directly
reflecting knee joint dysfunction, was delayed, by 2 weeks, over
time and was by far less complete at 2 months in matrilin-2-deficient
Fig. 5. Growth patterns of DRG neuron axons on different substrates analysed
by a stripe assay. DRG explants were grown for 24 hours on 22 mm glasses
that had been coated in stripes with laminin (L), poly-l-lysine (P), matrilin 2
(M), or laminin and matrilin 2 (L/M), fixed and immunostained using NF
antibodies. Within one experiment, DRG axons were grown on slides coated
with alternating stripes of laminin and poly-l-lysine (PLL) (A), matrilin 2 and
PLL (B), matrilin 2 and laminin (C) or laminin and a mixture of laminin and
matrilin 2 (D).
Fig. 6. Upregulation of matrilin 2 and 4 in nerves after lesion. Matrilin-2
expression analysed by immunofluorescence staining of transverse sections
from damaged (A,C) and intact (B,D) femoral (A,B) and sciatic (C,D) nerves
dissected from adult wild-type mice 3 or 5 days after transection of the femoral
or sciatic nerve, respectively. Matrilin-4 expression analysed by
immunofluorescence staining of transverse sections from damaged (E) and
intact (F) sciatic nerve 7 days after transection. (A-F) Note the strong
upregulation upon injury (n=4 mice per experiment). Scale bars: 100 µm.
(G) Upregulation of matrilin 2 in damaged sciatic nerves 7 days after nerve
injury revealed by western blotting. Samples from intact nerves, as well as
proximal and distal stumps of injured nerves, were analysed using antibodies
against matrilin 2 and β-actin. (H) RT-PCR analysis was performed on
lesioned femoral nerves from wild-type (+/+) and matrilin-2-deficient adult
(–/–) animals 5 days after nerve lesion. Note the higher expression of matrilin
4 in samples from lesioned nerve from mutant animals compared with wild-
type animals. Expression of Ddost served as an internal control.
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mice compared with wild-type littermates (Fig. 8A). No differences
between the genotypes were seen for the FBA. When the changes
in individual functional abilities after the first post-operative week
were normalized to the individual animal degree of walking
impairment 1 week after injury by calculating individual recovery
indices for both the FBA and the HTA, and the mean of these, the
stance recovery index (Fig. 8C), it became apparent that knee
function is, indeed, less successfully restored in matrilin-2-deficient
mice compared with wild-type littermates.
Impaired functional recovery of matrilin-2-deficient mice is not
associated with a regeneration failure of motoneurons, deficient
axonal regeneration or reduced Schwann cell proliferation
To identify possible reasons for the impaired functional recovery
in matrilin-2-deficient mice, we performed retrograde tracing
experiments for motoneurons that had successfully regenerated and
morphometric analyses of their axons in mice used for functional
evaluations. Analyses of back-labelling experiments revealed that
similar numbers of motoneurons in both groups (matrilin-2-deficient
and wild type) had sent axons into only the inappropriate saphenous
(skin) branch of the femoral nerve, or into only the appropriate
quadriceps (motor) branch, or into both branches (Fig. 9A). In
addition, the total numbers of back-labelled motoneurons, reflecting
the degree of motoneuron survival in this experimental paradigm
(Simova et al., 2006), were similar in matrilin-2-deficient and wild-
type mice. Analyses of axonal diameters and g-ratios, estimates of
the degree of axonal remyelination, in regenerated nerves also did
not reveal significant differences between the genotypes (Fig. 9B,C).
Thus, the incomplete recovery of function in matrilin-2-deficient
mice was not related to failure of motoneurons to re-innervate
peripheral targets or deficits in axonal regeneration.
We also looked at the proliferation capacity of SCs after nerve
lesion. Mice were injected with BrdU 4 hours before they were
sacrificed 3, 5 and 7 days after nerve lesion. Numbers of BrdU/p75
double-positive cells or Ki67/p75 double-positive cells were
determined on transverse sections. For each time point and each
genotype, at least three animals were analysed and 10-30 sections
were evaluated per animal. We could not observe a significant
difference in the numbers of double-positive cells comparing
sections from wild-type and matrilin-2-deficient animals at any of
the three time points analysed (Fig. 9E; supplementary material Fig.
S5). This finding demonstrates that the proliferation capacity of
matrilin-2-deficient SCs during regeneration is not impaired.
Delayed functional recovery in matrilin-2-deficient mice is
associated with retardation of axonal regeneration
As different in vitro approaches revealed that matrilin 2 is a
permissive substrate for axonal growth, we asked the question is
axonal regeneration also slowed down in matrilin-2-deficient mice.
Rather than measuring the speed of axonal regrowth, we counted
the regenerated axons at different distances from the lesion site at
one time-point, to estimate the overall progression of regeneration.
A similar approach has been used before where the process of
asynchronous regrowth of individual axons over prolonged time-
periods was analysed in great detail (Brushart et al., 2002).
According to results of our pilot experiments using femoral nerves
that were allowed to regenerate for 3, 4, 5, 6 and 9 days, respectively
(data not shown), we selected a 5-day survival period as optimal
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Fig. 7. Immunohistochemical analysis of matrilin-2 expression following
nerve injury. Transverse sections from the proximal (A,C,E,G) and distal
(B,D,F,H) nerve stumps 7 days after nerve transection in adult mice. (A,B) Co-
immunostaining using anti-NF antibody to visualize axons (green) and anti-
matrilin-2 (red) antibodies . Note the mutually exclusive pattern revealing the
absence of matrilin-2 expression in axons. (C,D) Matrilin 2 (green) is also not
detectable in myelin sheaths visualized with an antibody against myelin basic
protein (MBP, red). (E-H) Matrilin 2 (red) colocalizes with the SC marker p75
(green) (E,F) and matrilin 2 (green) is also detectable in basement membranes,
as indicated by its colocalization with nidogen 1 (red) (G,H). In A-F, cell
nuclei were visualized with DAPI (blue). Shown are representative staining
examples performed on sections from four independent wild-type mice. Scale
bars: 20 µm in A,B,E-H; 10 µm in C,D.
Fig. 8. Time course and degree of motor recovery after femoral nerve lesion in
matrilin-2-deficient (matrilin 2–/–) and wild-type (matrilin 2+/+) mice. Shown
are heel-tail angles (A), foot-base angles (B) and stance recovery indices (C) at
different time-points after nerve transection and repair. Asterisks indicate
significant differences between matrilin-2-deficient and wild-type mice (n=7
per group) at the respective time point (*P<0.05).
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time-point for our analysis. The counting of regenerated axons,
visualized by β-tubulin immunohistochemistry, in transverse
sections from regenerated nerves revealed lower numbers of axons
in matrilin-2-deficient mice compared with wild-type littermates at
3 to 5 mm from the lesion site (Fig. 9D; supplementary material
Fig. S1). This observation indicates that axonal regeneration is
retarded in the absence of matrilin 2 and correlates well with the
delay in functional recovery of matrilin-2-deficient mice and with
the data obtained from our in vitro studies.
Discussion
Our work provides, for the first time, insights into the functions of
matrilin 2. We show that matrilin 2, which is produced and secreted
into the ECM by SCs in the peripheral nervous system, potently
enhances axonal growth and SC migration in vitro. In vivo, these
functions appear to be important during peripheral nerve
regeneration, a conclusion based on the finding of defective
restoration of function in mice incapable of re-expressing matrilin
2 after nerve injury.
Expression pattern of matrilin 2 in the peripheral nervous
system
It had been previously reported that matrilin 2 is expressed in a
variety of tissues, including the CNS dura and pia mater, and the
PNS endoneurium (Piecha et al., 1999). In this study, we show that,
in the PNS, matrilin 2 is expressed by SCs. Co-labelling experiments
using antibodies against the SC marker p75 and the basal lamina
marker nidogen1 in combination with matrilin-2-specific antibodies
revealed that matrilin 2 is expressed in non-myelinating SCs and
is secreted into their basal lamina tubes. In the PNS, we found high
levels of matrilin-2 expression by semi-quantitative RT-PCR
and immunohistochemistry in embryonic tissue throughout
development, whereas only low levels of expression were detectable
by immunoblotting and immunohistochemical analyses in adult
peripheral nerves. Upon injury of the sciatic or femoral nerves a
strong upregulation was observed. Our finding adds a novel
molecule to the long list of SC products. Characteristic for many
of these SC-derived molecules is that, in rodents, they are highly
expressed during early development, downregulated during
postnatal life to very low or undetectable levels in the adult PNS
and are re-expressed following nerve damage. Thus, our
observations indicate a similar developmental and injury-related
regulation of matrilin-2 expression. The progeny of once
myelinating SCs in the distal nerve stump initially acquires a non-
myelinating SC phenotype. Myelin genes are downregulated
(LeBlanc and Poduslo, 1990; Trapp et al., 1988), whereas
neurotrophic factors and ECM molecules (laminin, fibronectin,
collagens), which are important for fasciculation, axonal
prolongation and SC migration are strongly upregulated (Bixby et
al., 1988; Brodkey et al., 1993; Bunge, 1983; Daniloff et al., 1986;
Martini, 1994). Interestingly, the injury-related upregulation of
matrilin-2 expression was more pronounced in the distal stump into
which axons regenerate than in the proximal nerve stump. Similarly,
following nerve injury SCs proliferate by far more in the distal than
in the proximal nerve stump (Bunge, 1987; Clemence et al., 1989).
So it appears that an environment that stimulates dedifferentiation
and proliferation of SCs is also favourable for high levels of matrilin-
2 expression. We did not observe any influence of matrilin 2 on
SC proliferation during development (supplementary material Fig.
S4) or peripheral nerve regeneration; however, other major events
occurring in regenerating peripheral nerves such as axonal growth
and SC migration can be stimulated by matrilin 2. It is likely that
the colocalization of matrilin 2 with laminin and collagen IV, main
components of the basal lamina tubes, is of functional relevance
during the regeneration process.
Effects of matrilin 2 on cell migration and axonal outgrowth
The development of the PNS and its functionality later in the adult
are strongly influenced by the ECM produced by SCs. Of particular
functional importance are ECM proteins that participate in the
formation of the endoneural tubes (basal laminae) around individual
Fig. 9. Morphological evaluation of muscle reinnervation and speed of
regeneration and Schwann cell proliferation. (A) Numbers of motoneurons
innervating the motor or sensory branches only, or both branches, as well as
the total number of regenerated motoneurons 3 months after nerve repair.
(B) Relative degrees of myelination estimated by g-ratios (axon/fibre diameter
ratios) and diameters of regenerated axons (C) evaluated in semi-thin sections
from regenerated nerves cut ~2 mm distal from the site of transaction 3 months
after nerve repair. (D) Analysis of axonal regrowth 5 days after nerve lesion.
Numbers of regenerated axons, identified by β-tubulin immunofluorescence,
present in transverse sections of femoral nerves collected at distances of 3, 4
and 5 mm distal to lesion site. Asterisks indicate significant differences
between matrilin-2-deficient and wild-type mice (**P<0.01) in numbers of
Tuj1-positive axons 5 mm distal from the site of transection. (E) Numbers of
proliferating SCs in the distal stumps 3 days (3 dpl), 5 days (5 dpl) and 7 days
(7 dpl) after lesion in wild-type (+/+) and matrilin-2-deficient (–/–) adult mice.
Animals were sacrificed following a 4-hour pulse of BrdU applied by
injection. Transverse sections of femoral nerves distal to the site of lesion were
incubated with antibodies against p75 (SC marker) and BrdU. Only cells
positive for both signals were counted. No statistically significant differences
were observed between mutant and control at any time point. Similar results
were obtained when antibodies against Ki-67 (proliferation marker) were used
instead of BrdU.
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axons as these are implicated in developmental and repair processes
such as axonal growth, cell migration, axonal branching and
myelination (Chernousov and Carey, 2000). The best example is
laminin, which is known for its potency to support cell migration
and axonal outgrowth, as well as its essential role in myelination
(Chen and Strickland, 2003). As we show here, matrilin 2, similar
to laminin, is capable of promoting axonal growth, as well as
migration and adhesion of SCs. Remarkably, when used as a uniform
coating substrate in vitro, matrilin 2 supports migration of both, cell
line- and embryonic DRG-derived, SCs better than laminin. Under
choice conditions in stripe assays, matrilin 2 is a very good substrate
and supports growth of DRG neuron axons almost as efficiently as
does laminin. This is especially noteworthy considering that laminin
is one of the most permissive substrates for axonal growth (Snow et
al., 1996; Vielmetter et al., 1990). Interestingly, DRG neuron axons
show a higher preference for growth on a mixture of laminin and
matrilin 2 when compared with surfaces coated with laminin alone,
arguing for a unique matrilin-2-mediated growth-promoting activity.
These findings are further substantiated by the deficits in axonal
growth and SC migration observed in DRG culture assays employing
matrilin-2-deficient embryos. These deficits can be rescued by adding
matrilin 2 to the cultures or using it as a coating substrate,
demonstrating the direct effect on SC migration and axonal outgrowth.
It is known that laminin influences cellular behaviour via binding
to cell surface receptors such as dystroglycan (Yamada et al., 1996)
or integrins (Chernousov et al., 2007; Feltri et al., 2002); by contrast,
the mechanisms underlying the observed effects of matrilin 2 are
currently poorly understood. Except for matrilin 4, all matrilins
mediate cell attachment, but the binding does not lead to the
formation of focal contacts and reorganization of the actin
cytoskeleton. Cell surface proteoglycans may promote the
attachment, as cells deficient in glycosaminoglycan biosynthesis
adhere less well to matrilin 3 (Mann et al., 2007). We can thus only
speculate that multiple interactions of matrilin 2, enabled by the
common matrilin domain structure, are important in mediating the
effects reported here.
Matrilin 2 in peripheral nerve regeneration
Using a recently described functional assay (Irintchev et al., 2005),
we provide direct evidence that matrilin 2 is important for recovery
after peripheral nerve injury in adult animals. Recovery of the knee
extension function of the quadriceps muscle after femoral nerve
transection and surgical repair in matrilin-2-deficient mice was both
delayed in time and finally less complete compared with wild-type
littermates. The delay in the time-course of functional recovery is
entirely explainable by the in vitro findings that matrilin 2 promotes
SC migration and axonal elongation. We can assume that absence
of matrilin 2 in the denervated basal lamina tubes causes slower
regeneration by reducing the rate of axonal outgrowth and,
simultaneously, the rate of migration of the SCs that guide the tips
of regenerating peripheral axons (Son and Thompson, 1995). This
interpretation is supported by the observation of lower numbers of
regenerated axons distal to the nerve repair site in matrilin-2-
deficient mice compared with wild-type animals 5 days after surgery.
More difficult is the explanation of the finding that functional
recovery at 2 months after injury is less complete in matrilin-2-
deficient than in wild-type mice. This time-period is sufficient for
maximum recovery, reaching 60-70% of the preoperative values in
wild-type mice (Ahlborn et al., 2007; Eberhardt et al., 2006; Simova
et al., 2006), and long enough to surpass the delay in recovery. This
poor outcome was not associated with failure of regeneration as
numbers of back-labelled regenerated motoneurons, as well as
diameters and degree of myelination of regenerated axons, were
similar in knockout and wild-type mice. We can speculate that
matrilin 2 also has beneficial functions during nerve regeneration
that have not been revealed by this study. Although matrilin 2 has
no effect on SC proliferation, it is possible that it improves the
functional outcome of nerve regeneration by, for example,
influencing the expression pattern of regeneration-related molecules
by SCs or binding to yet unidentified receptors on the regenerating
axons and thus exerting, directly or indirectly, ‘trophic’ effects on
the injured motoneurons. In addition, impacts of matrilin 2 on the
regeneration of sensory neurons and subsequent afferent-related
influences on recovery of motor functions have to be considered.
We can also speculate that after nerve injury in wild-type mice,
matrilin 2 is expressed by SCs at denervated endplates and promotes
endplate reinnervation when motor axons regrow into the muscle.
Disturbances of endplate reinnervation by absence of matrilin 2 in
knockout mice may lead to a significant and long-lasting muscle
malfunction that limits motor recovery. The plausibility of the latter
notion is supported by observations indicating that aberrant endplate
reinnervation is a factor that limits restoration of function after nerve
lesion (Guntinas-Lichius et al., 2005b). Here, we did not exploit
the effect of matrilin-2 deficiency on endplate reinnervation,
considering previously encountered technical difficulties in
visualization of mouse axonal arborizations by
immunohistochemistry (Guntinas-Lichius et al., 2005a). However,
further studies that aim to elucidate the role of matrilin 2 at endplates
appear apparently warranted.
Matrilin 2 is not the first basal lamina component shown to be
essential for peripheral nerve regeneration. Deficient axonal
regeneration has also been observed after genetic ablation of the
laminin γ1 chain in SCs, which leads to downregulation of most
laminin isoforms in the peripheral nerves, or ablation of the laminin
receptor α7β1 integrin, which is upregulated in axotomized
motoneurons (Chen and Strickland, 2003; Werner et al., 2000).
However, intact laminin-deficient mice have motor deficits (tremor,
ataxia) and impaired myelination in the PNS (Chen and Strickland,
2003; Wallquist et al., 2005), abnormalities that have been observed
in neither this nor in previous studies on the matrilin-2-deficient
mouse (Mates et al., 2004). Therefore, we can assume that laminin
and matrilin 2 have both overlapping and distinct functions in vivo,
e.g. promotion of axonal elongation and myelination, respectively.
It had been shown before that in matrilin-2-deficient animals other
family members are not significantly upregulated, and the
expression levels and distribution of matrilin-2 interaction partners
are not grossly changed (Mates et al., 2004). Surprisingly, in
peripheral nerves of matrilin-2-deficient animals, we observed a
compensatory upregulation of matrilin 4 upon injury to levels
significantly higher than in wild-type littermates. However, the
impaired regeneration in matrilin-2 mutants demonstrates that this
upregulation is not able to rescue the absence of matrilin 2, which
can also be explained by the differences in the domain structures
between these family members.
Our study reveals the beneficial impact of matrilin 2 on
peripheral nerve regeneration. Beyond its contribution to
understanding the roles of matrilin 2 in vivo, this knowledge might
have implications in clinical settings. For example, it is
conceivable that matrilin-2 peptides would be beneficial if used
as coating substrates for artificial nerve conduits that bridge large
nerve gaps, a reconstructive surgical approach typically associated
with poor functional recovery.
Journal of Cell Science 122 (7)
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Materials and Methods
RNA analysis
Total RNA was isolated from embryonic DRG and different types of mammalian
cells by RNeasy mini kit (Qiagen). For semi-quantitative RT-PCR, 1-5 µg of total
RNA was transcribed into cDNA using the SuperScript II Rnase H-reverse
transcriptase (Invitrogen). For PCR reactions, one unit of AmpliTaq DNA polymerase
(Invitrogen) and 0.5-2.0 µl of cDNA were used in 25 or 50 µl amplification buffer.
The primer pairs used were: matrilin 2, 5´-TGCAAGAGATGCACTGAAGG-3´ (fwd.)
and 5´-ATTTCCTTGGCTGAGCTGAA-3´ (rev.); GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) 5´-ACCACAGTCCATGCCATCAC-3´ (fwd.) and 5´-
TCCACCACCCTGTTGCTGTA (rev.); matrilin 4 5´-GACTCGTATTTCTGTC -
GTTGCC-3´ (fwd.) and 5´-AACCATCCACCAGGAGAACAAG-3 (rev.); and Ddost
5´-GGTCCCCTTTGATGGTGATGAC-3´ (fwd.) and 5´-TGCTGAAGATGA -
AGAGCCCG-3´ (rev.). For every time point and every genotype, tissue from two or
three different animals was used. In situ hybridization was performed essentially as
described previously (Sonnenberg et al., 1991). A 592 bp fragment corresponding to
the unique segment and small part of VWA2 domain of mouse matrilin 2 was cloned
from RZPD clone (I.M.A.G.E. Gp998F188539Q3) using following primers: 5´-
CCACGCAGGTACCCAGAGTA-3´ (fwd) and 5´-TCAGCGGCCGCTCTGTAT -
TTT-3! (rev). 35S-labeled riboprobes were prepared following standard protocols.
Expression and purification of recombinant matrilin 2
The fragment containing a precursor of the full-length matrilin 2 was recovered from
the RZPD clone (IMAGE Gp998F188539Q3), by suitable restriction enzymes and
then inserted into pcDNA3.1-Myc/His6 (C). The recombinant plasmid was introduced
into Chinese Hamster Ovary (CHO) cells using Lipofectamin 2000 reagent, according
to the manufacturer’s instructions (Invitrogen). The transfected cells were selected
using 800 µg/ml G418 (Geneticin, Invitrogen) and grown to confluence. Secretion
of matrilin 2 into the culture medium was verified by immunocytochemistry and
SDS-PAGE with immunoblotting, using antibody against the Myc epitope. The protein
was purified using Ni-NTA technology under denaturating condition. In parallel,
matrilin-2 recombinant protein with His6-tag on 5´-end was purified using native
conditions. Both proteins were used in different experiments and showed similar
activities.
Cell culture
In all cell culture experiments, 12 mm or 22 mm glass coverslips were coated first
with poly-D-ornithine (PDO, 10 µg/ml, overnight incubation at room temperature),
washed once in distilled water, air-dried and coated with either laminin (20 µg/ml)
(Roche), fibronectin (20 µg/ml) (Sigma), matrilin 2 (20 µg/ml) (R. Wagener) or a
mixture of laminin and matrilin 2 (20 µg/ml of each) by overnight incubation at 4°C.
Neural crest stem cells (Monc1) were cultured as described previously (Rao and
Anderson, 1997). Cultures of DRG explants were prepared as described previously
(Lumsden et al., 1981). Cultures of dissociated adult DRG neurons were prepared
as described by previously (Svenningsen et al., 2003). The branching of neurites was
analysed essentially as described (Bouquet et al., 2004).
The agarose drop migration assay was performed as described by Milner (Milner
et al., 1997a). In this assay, immortalized rat S16 SCs were allowed to migrate for
24-48 hours. The migration was monitored using a phase-contrast microscope. The
adhesion assays were performed according to published protocols (Chernousov et
al., 2001; McGarvey et al., 1984; Milner et al., 1997a). All experiments were carried
out in triplicate.
Cell migration and neurite outgrowth from DRG explants
DRG (E12) explants were placed on the dishes coated with different ECM
substrates. Cell migration assay from DRGs was performed as described
(Chernousov et al., 2001). Sox10-specific antibodies (a marker for embryonic SCs)
and DAPI (cell nuclear staining) were used and samples analysed by
immunofluorescence. The number of cells and the distance from the edge of a
ganglion to the leading edge of migrating SCs was determined. Four measurements
were made in different directions of radial migration for each ganglion and averaged.
To analyse neurite outgrowth, ganglia were incubated in complete culture medium
supplemented with NGF (Invitrogen, 20 ng/ml) for 24 hours, followed by
immunostaining with anti-neurofilament (NF) antibodies or combination of anti-
neurofilament and anti-sox10 antibodies.
Stripe assay
Stripe assays were performed as described previously (Vielmetter et al., 1990). Silicon
matrix was obtained from Jürgen Jung (Max-Planck Institute, Tübingen, Germany).
DRG explants and dissociated cells were grown for 24 hours on 22 mm glasses coated
with different proteins as described above, fixed and immunostained with NF
antibodies. All experiments were carried out in triplicate and performed at least three
times independently.
Immunohistochemistry, antibodies and determination of
proliferation rates
Immunohistochemistry analyses on cryosections or culture explants were performed
as described previously (Sonnenberg-Riethmacher et al., 2001). The following
antibodies were used for immunohistochemistry at optimal dilutions: rabbit polyclonal
against mouse matrilin 2 [(Piecha et al., 1999) 1:100], goat polyclonal against p75
(Santa Cruz, 1:30), rat monoclonal against MBP (1:200) and nidogen 1 (Chemicon,
1:40), mouse monoclonal against NF160, rabbit polyclonal against NF200, neuron-
specific class III tubulin (Tuj1), β-actin (all Sigma, 1:200), Myc (9E10, Upstate,
1:5000), and mouse monoclonal against Ki-67 (Novocastra, NCL-Ki67-MM1, 1:200)
and Sox10 hybridoma supernatant (K. Kuhlbrodt and M. Wegner, 1:5). Secondary
antibodies against mouse, rat, rabbit and goat conjugated to Cy2 or TRITC were
obtained from Dianova (Dianova, Hamburg) and applied at optimal dilutions as
required.
In order to determine the numbers of proliferating SCs, mice were killed 3, 5 and
7 days after nerve lesion. Four hours prior to sacrifice, mice were injected with BrdU
(40 µg/g body weight). Transverse sections (10 µm) of the femoral nerve distal to
the lesion were cut and stained with anti-p75 and in some experiments co-labelled
with anti-Ki67 antibodies. BrdU-positive nuclei were identified using mouse
monoclonal anti-BrdU antibody (Roche, Clone BMC 9318). At least triplicates were
used for each genotype at every time point.
Animals and surgical procedures
For cell culture experiments and expression assays, we used C57Bl/6 mice, ErbB3
and matrilin-2-deficient mice. The generation of the ErbB3 and matrilin-2 mutant
mice has been described previously (Mates et al., 2004; Riethmacher et al., 1997).
In addition to adult animals (3 months old), mice at different stages of embryonic
(E12, E14, E16, E18) and early postnatal (P0, P1, P2, P3) development were studied.
All animals were bred at the central animal facility of the University Medical Center
Hamburg-Eppendorf. The mice were treated according to the German law on
protection of experimental animals after approval by the responsible committee of
The State of Hamburg.
For surgery, the 3-month-old matrilin-2-deficient mice and wild-type (wt) littermates
were anesthetized by intraperitoneal injections of 0.4 mg/kg fentanyl (Fentanyl-
Janssen, Janssen, Neuss, Germany), 10 mg/kg droperidol (Dehydrobenzperidol,
Janssen) and 5 mg/kg diazepam (Valium 10 Roche, Hoffmann-La Roche, Grenzach-
Wyhlen, Germany). The surgeries to lesion left femoral or sciatic nerves were
performed as described previously (Simova et al., 2006).
Analysis of motor function, retrograde labelling of regenerated
motoneurons and analysis of regrowth of regenerating axons
Functional recovery after femoral nerve repair was assessed by single frame motion
analysis (SFMA) as described (Irintchev et al., 2005). Retrograde labelling and
counting of back-labelled cells were performed as described (Simova et al., 2006).
To analyze the speed of regeneration, nerve injury was performed in matrilin-2-
deficient and wild-type mice, and 5 days later the animals were perfused, the femoral
nerves were removed, post-fixed overnight, incubated in 30% sucrose in buffer
overnight, frozen and cut transversely (serial sections of 10 µm) on a cryostat. After
staining with anti-tubulin (Tuj1) antibodies, sections were examined under a
fluorescence microscope (Zeiss) with appropriate filter sets. Numbers of Tuj1-positive
axons were measured 3, 4 and 5 mm distal to the transection site.
Morphometric and statistical analysis
Femoral nerves were dissected from animals fixed by perfusion (see above) and further
analysed as described (Simova et al., 2006). In all experiments, statistical analysis
was performed using ‘GraphPad Prism 4’ or MiniTab (Release 15) software by one-
way ANOVA test for repeated measurements. Tukey’s multiple comparison test was
used as a post-hoc test for multiple comparisons of group mean values. Data are
shown as mean values with standard errors of the mean.
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